The Effect of Palonosetron on the QTc Interval During Perioperative Period
Phase of Trial: Phase II
Latest Information Update: 14 Oct 2013
At a glance
- Drugs Palonosetron (Primary)
- Indications Postoperative nausea and vomiting
- Focus Pharmacodynamics
- 04 Feb 2013 Primary endpoint amended as reported by ClinicalTrials.gov.
- 04 Feb 2013 Planned number of patients changed from 308 to 100 as reported by ClinicalTrials.gov.
- 01 Dec 2012 Recruitment completed, according to results published in the British Journal of Anaesthesia.